This week on Pharma Research VIDEO Report: 1) IMS Health’s acquisition of assets of Cegedim vastly increases IMS’ size and may lead to new insights 2) New pharmaceutical research registry announcements. 3) Johnson & Johnson announces new alliances to explore early-stage therapeutic innovations for pharma, medical devices,diagnostics and consumer health. 4) Perelman School of Medicine reveals health policy researchers limit their social media use to communicate research findings 5) IDC Health Insights releases a new report to help payers effectively reach & engage segments of their member populations, which have changed due to ACA.
Med cost up 3-5%; pharmacos cut MD speaker fees; FDA eases adverse event reporting (PRVR–3/10/14)
This week’s Pharma Research VIDEO Report: 1) Costs for medications will rise 3-5% this year, after having dramatically slowed in recent years. 2) Pharmaceutical companies have radically reduced what they pay doctors to speak, well at least many of them have. 3) Generic drug manufacturers will fight FDA proposals that they be required to update their product labels when new information with concerns about branded equivalents appear. 4) FDA will make availability of adverse event reports much easier to find and collect. 5) Health care providers say the Affordable Care Act needs changes and revisions, but overwhelmingly see it as a positive step for U.S. healthcare. 6) The multimillion dollar injectable drug market for chronic conditions like diabetes may be in or a shakeup if Mir Imran’s “Robotic Pill” gets FDA approval. It is in preclinical testing. 7) Media technology company Sticky wins the PM360 award for most innovative company. 8) A press release last week declared the first broadcast medical marijuana commercial. The release pointed to Comcast as the broadcaster. Since the taping of this video, PRVR has learned that this release was part of a misleading campaign. We apologize for this mistaken report.
Here is the link to the commercial:
https://www.marijuanadoctors.com/content/page/view/91
For Johnson and Johnson, Millward Brown’s brand equity comparison leads way to emotional MR; Social media expert Perry Marshall explains why Facebook revenues will triple (RBDR–11/14/2013)
Today: 1) The J&J Consumer Products alteration of its marketing research through Millward Brown’s brand equity comparative tool is a crucial building block to achieving emotional brand/consumer connections.
2) Social media research guru Perry Marshall explains why Facebook will triple its revenues by the summer of 2015 and why Facebook advertising works better for B2C than B2B. Bonus information: Marshall’s http://isfbforme.com website will test Facebook advertising as a value for you and your business.
Sponsored by Socratic Technologies (http://www.sotech.com), whose proprietary tools and methodologies tackles marketing complexities so that you can make more confident business decisions.
RFL Communications, Inc. 